1/13
08:00 am
gdtc
CytoMed Therapeutics’ new year update and seeks shareholders’ feedback on proposal to improve shareholder value for their patient capital
Medium
Report
CytoMed Therapeutics’ new year update and seeks shareholders’ feedback on proposal to improve shareholder value for their patient capital
12/8
08:00 am
gdtc
CytoMed Therapeutics Announces Novel First-In-Human Clinical Trial Collaborations with Renowned and Prestigious Hospital Partner to Advance Its Off-The-Shelf Donor-Derived Gamma Delta T Cells Allogeneic Technology to Treat Cancers in Malaysia
Medium
Report
CytoMed Therapeutics Announces Novel First-In-Human Clinical Trial Collaborations with Renowned and Prestigious Hospital Partner to Advance Its Off-The-Shelf Donor-Derived Gamma Delta T Cells Allogeneic Technology to Treat Cancers in Malaysia
11/18
08:00 am
gdtc
CytoMed Therapeutics Completes Acquisition of T Cell Technology from UK to Treat Cancers in China and India
Low
Report
CytoMed Therapeutics Completes Acquisition of T Cell Technology from UK to Treat Cancers in China and India
11/6
08:00 am
gdtc
CytoMed Therapeutics Secures Non-Dilutive Investment for Subsidiary LongevityBank from ICH Capital and Updates on New China Strategy
High
Report
CytoMed Therapeutics Secures Non-Dilutive Investment for Subsidiary LongevityBank from ICH Capital and Updates on New China Strategy
10/22
08:00 am
gdtc
CytoMed Therapeutics’ Chairman Increases Effective Holdings to 21.95%
Low
Report
CytoMed Therapeutics’ Chairman Increases Effective Holdings to 21.95%